The therapeutic use of psychedelic drugs: Legal, policy, and neuroscientific perspectives.
Pharmacology, biochemistry, and behavior November 1, 2025 Shadan Rahmani, Rachel Crupi, Anthony L Riley et al.
A resurgence of interest in psychedelic drugs for therapeutic use is underway, with anecdotal and evidence-based reports suggesting they may treat depression, anxiety, PTSD, and substance abuse. However, available data are limited and their use remains controversial. This paper reports on talks by eighteen experts at a symposium covering safety and effectiveness of psychedelic-assisted therapies, brain systems involved, ethical issues, access pathways, regulation, and patenting. The symposium revealed the potential of psychedelics for treating psychiatric disorders and the scientific, legal, and policy challenges to realizing that potential.